Keywords：专著资料, 全文在线浏览, 腰椎结核寒性脓肿的治验1995.10.26
Section Index
Application of Interferon in Hematological Diseases, February 27, 1995
Interferon (IFN-α) is produced by the body's biological cells under the influence of inducers and is a highly active glycoprotein. White blood cells produce IFN-α, fibroblasts produce IFN-β, and T lymphocytes produce IFN-γ.
Indications: chronic myelogenous leukemia, multiple myeloma, malignant lymphoma, malignant melanoma.
The optimal dosage is (1–3) × 10^7^ U/day, or even higher, with a treatment course of about one month. Generally, it is believed that the dosage of this drug is positively correlated with its efficacy.
This chapter is prepared for online research and reading; for external materials, please align with original publications and the review process.